Drug-DNA interaction protocols /

Saved in:
Bibliographic Details
Imprint:Totowa, NJ : Humana Press, ©1997.
Description:1 online resource (x, 278 pages) : illustrations
Language:English
Series:Methods in molecular biology ; v. 90
Methods in molecular biology (Clifton, N.J.) ; v. 90.
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/11170746
Hidden Bibliographic Details
Other authors / contributors:Fox, Keith R.
ISBN:9781592595747
159259574X
1280837403
9781280837401
9786610837403
6610837406
089603447X
9780896034471
Notes:Includes bibliographical references and index.
Electronic reproduction. [Place of publication not identified] : HathiTrust Digital Library, 2010.
Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. http://purl.oclc.org/DLF/benchrepro0212
English.
digitized 2010 HathiTrust Digital Library committed to preserve
Print version record.
Summary:In Drug-DNA Interactions, expert researchers describe powerful molecular techniques designed to illuminate and explore the interaction of drugs and ligands with DNA, often perfected in their own laboratories, . These easily reproducible methods involve sequence recognition properties, as well as physical approaches to measuring both the strength of interaction and the mode of drug binding to DNA. Drug interactions are also examined from a cellular perspective and for their usefulness in the development of new therapeutic agents. Drug-DNA Interactions will be highly useful to all investigators needing the kind of detailed experimental and technical information often omitted from scientific papers. Those wishing to expand their repertoire of experimental techniques or to improve their current techniques will also find these powerful methods particularly helpful in elucidating the action of existing therapeutic agents, as well as in designing new anticancer drugs with improved action and reduced toxicity.
Other form:Print version: Drug-DNA interaction protocols. Totowa, NJ : Humana Press, ©1997 089603447X
Standard no.:10.1385/089603447X.

MARC

LEADER 00000cam a2200000 a 4500
001 11170746
006 m eo d
007 cr gn||||auuu|
008 080604s1997 njua ob 001 0 eng d
005 20250303135713.8
019 |a 123982420  |a 605505299  |a 608554565  |a 642460934  |a 964932501  |a 967627630  |a 994787188  |a 1005744398  |a 1033579847  |a 1043305013  |a 1045347461  |a 1078835951  |a 1078854404  |a 1081210482  |a 1087330565  |a 1109103889  |a 1113795650  |a 1120915592  |a 1159662402  |a 1164869522  |a 1166245519  |a 1167205071  |a 1179902507  |a 1203761970  |a 1204523528  |a 1228534390 
020 |a 9781592595747  |q (Springer e-ISBN) 
020 |a 159259574X  |q (Springer e-ISBN) 
020 |a 1280837403 
020 |a 9781280837401 
020 |a 9786610837403 
020 |a 6610837406 
020 |z 089603447X 
020 |z 9780896034471 
024 7 |a 10.1385/089603447X.  |2 doi 
035 9 |a (OCLCCM-CC)230743523 
035 |a (OCoLC)230743523  |z (OCoLC)123982420  |z (OCoLC)605505299  |z (OCoLC)608554565  |z (OCoLC)642460934  |z (OCoLC)964932501  |z (OCoLC)967627630  |z (OCoLC)994787188  |z (OCoLC)1005744398  |z (OCoLC)1033579847  |z (OCoLC)1043305013  |z (OCoLC)1045347461  |z (OCoLC)1078835951  |z (OCoLC)1078854404  |z (OCoLC)1081210482  |z (OCoLC)1087330565  |z (OCoLC)1109103889  |z (OCoLC)1113795650  |z (OCoLC)1120915592  |z (OCoLC)1159662402  |z (OCoLC)1164869522  |z (OCoLC)1166245519  |z (OCoLC)1167205071  |z (OCoLC)1179902507  |z (OCoLC)1203761970  |z (OCoLC)1204523528  |z (OCoLC)1228534390 
040 |a YNG  |b eng  |e pn  |c YNG  |d CNTRU  |d CUV  |d OKU  |d GW5XE  |d IDEBK  |d OCLCQ  |d COO  |d OCLCQ  |d VVL  |d UWW  |d OCLCO  |d E7B  |d OCLCE  |d CASUM  |d OCLCA  |d OCLCF  |d YDXCP  |d OCLCQ  |d VT2  |d OTZ  |d OCLCA  |d BUF  |d INARC  |d MERER  |d OCLCQ  |d U3W  |d OCLCQ  |d YOU  |d OCLCO  |d CANPU  |d OCLCA  |d LND  |d OCLCO  |d OCLCQ  |d OCLCO  |d AU@  |d OCLCQ  |d U3G  |d HS0  |d UKBTH  |d LIP  |d OCLCA  |d UWK  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCL  |d OCLCO  |d WSU  |d OCLCO 
042 |a dlr 
049 |a MAIN 
050 4 |a QP624.75.D77  |b D78 1997 
060 4 |a W1  |b ME9616J v.90 1997 
060 4 |a QU 58.5  |b D794 1997 
072 0 |a X380 
072 7 |a PSB.  |2 bicssc 
072 7 |a SCI013020.  |2 bisacsh 
084 |a 42.13  |2 bcl 
245 0 0 |a Drug-DNA interaction protocols /  |c edited by Keith R. Fox. 
260 |a Totowa, NJ :  |b Humana Press,  |c ©1997. 
300 |a 1 online resource (x, 278 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Methods in molecular biology ;  |v v. 90 
504 |a Includes bibliographical references and index. 
505 0 |a DNase I footprinting / Keith R. Fox -- Quantitative DNA footprinting / James C. Dabrowiak, Jerry Goodisman, Brian Ward -- Uranyl photoprobing of DNA Structures and drug-DNA complexes / Niels Erik Møllegaard, Peter E. Nielsen -- Diethylpyrocarbonate and osmium tetroxide as probes for drug-induced changes in DNA conformation in vitro / Christian Bailly, Michael J. Waring -- Footprinting studies with nucleosome-bound DNA / Philip M. Brown, Keith R. Fox -- A gel mobility shift assay for probing the effect of drug-DNA adducts on DNA-binding proteins / Suzanne M. Cutts, Andrew Masta, Con Panousis, Peter G. Parsons, Richard A. Sturm, Don R. Phillips -- An oligonucleotide crosslinking assay for the analysis of individual drug-binding sites / Suzanne M. Cutts, Con Panousis, Andrew Masta, Don R. Phillips -- DNA polymerase inhibition assay (PIA) for the detection of drug-DNA interactions / Thomas P. Dooley, Katherine L. Weiland -- Transcriptional footprinting of drug-DNA interactions / Don R. Phillips, Carleen Cullinane -- Determination of the DNA sequence specificity of alkylation damage using cleavage-based assays / John A. Hartley, Michael D. Wyatt -- PCR-based methods for detecting DNA damage and its repair at the subgene and single nucleotide levels in cells / Keith A. Grimaldi, John A. Hartley -- Analysis of DNA-binding antibodies / Jeremy S. Lee, Laura J. Latimer, Jamshid Tanha -- Immunofluorescent staining of chromosomes with DNA-binding antibodies / Jeremy S. Lee, Laura J. Latimer, Gary D. Burkholder -- Optical absorbance and fluorescence techniques for measuring DNA-drug interactions / Terence C. Jenkins -- Evaluation of drug-nucleic acid interactions by thermal melting curves / W. David Wilson, Farial A. Tanious, Maria Fernandez-Saiz, C. Ted Rigl -- Electric dichroism / Dietmar Porschke -- Calorimetric techniques for studying drug-DNA interactions / Harry P. Hopkins -- Methods for the studies of drug dissociation from DNA / Fu-Ming Chen. 
588 0 |a Print version record. 
533 |a Electronic reproduction.  |b [Place of publication not identified] :  |c HathiTrust Digital Library,  |d 2010.  |5 MiAaHDL 
538 |a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.  |u http://purl.oclc.org/DLF/benchrepro0212  |5 MiAaHDL 
583 1 |a digitized  |c 2010  |h HathiTrust Digital Library  |l committed to preserve  |2 pda  |5 MiAaHDL 
520 |a In Drug-DNA Interactions, expert researchers describe powerful molecular techniques designed to illuminate and explore the interaction of drugs and ligands with DNA, often perfected in their own laboratories, . These easily reproducible methods involve sequence recognition properties, as well as physical approaches to measuring both the strength of interaction and the mode of drug binding to DNA. Drug interactions are also examined from a cellular perspective and for their usefulness in the development of new therapeutic agents. Drug-DNA Interactions will be highly useful to all investigators needing the kind of detailed experimental and technical information often omitted from scientific papers. Those wishing to expand their repertoire of experimental techniques or to improve their current techniques will also find these powerful methods particularly helpful in elucidating the action of existing therapeutic agents, as well as in designing new anticancer drugs with improved action and reduced toxicity. 
546 |a English. 
650 0 |a DNA-drug interactions.  |0 http://id.loc.gov/authorities/subjects/sh90004877 
650 0 |a DNA probes.  |0 http://id.loc.gov/authorities/subjects/sh86007800 
650 0 |a DNA-binding proteins.  |0 http://id.loc.gov/authorities/subjects/sh97006173 
650 1 2 |a DNA  |x drug effects 
650 2 2 |a DNA Footprinting  |x methods 
650 2 2 |a DNA Probes 
650 2 2 |a DNA-Binding Proteins 
650 2 2 |a Polymerase Chain Reaction  |x methods 
650 6 |a Interactions ADN-médicament. 
650 6 |a Sondes ADN. 
650 6 |a Protéines de liaison à l'ADN. 
650 7 |a DNA probes  |2 fast 
650 7 |a DNA-binding proteins  |2 fast 
650 7 |a DNA-drug interactions  |2 fast 
650 1 7 |a Geneesmiddelen.  |2 gtt 
650 1 7 |a DNA.  |2 gtt 
650 1 7 |a Wetenschappelijke technieken.  |2 gtt 
655 2 |a Laboratory Manual  |0 https://id.nlm.nih.gov/mesh/D020484 
655 7 |a Laboratory manuals.  |2 lcgft  |0 http://id.loc.gov/authorities/genreForms/gf2014026120 
655 7 |a Manuels de laboratoire.  |2 rvmgf 
700 1 |a Fox, Keith R.  |0 http://id.loc.gov/authorities/names/nb97033639 
776 0 8 |i Print version:  |t Drug-DNA interaction protocols.  |d Totowa, NJ : Humana Press, ©1997  |z 089603447X  |w (DLC) 97217431  |w (OCoLC)37942210 
830 0 |a Methods in molecular biology (Clifton, N.J.) ;  |v v. 90. 
856 4 0 |u https://link.springer.com/10.1385/089603447X  |y Springer Nature 
903 |a HeVa 
929 |a oclccm 
999 f f |i 433cf27b-0c71-5420-b2c0-9dce81974f88  |s c9cdff31-8c7c-5524-9de7-2bba86d9402b 
928 |t Library of Congress classification  |a QP624.75.D77D78 1997  |l Online  |c UC-FullText  |u https://link.springer.com/10.1385/089603447X  |z Springer Nature  |g ebooks  |i 12531040